Thorac Cardiovasc Surg 2020; 68(07): 646-651
DOI: 10.1055/s-0039-1685472
Original Thoracic

Surgical Treatment of Bilateral Lung Cancers: Long-Term Outcomes and Prognostic Factors

1   Department of Thoracic Surgery, European Institute of Oncology, Milan, Italy
2   Department of Oncology and Emato-oncology Università degli Studi di Milano, Milan, Italy
,
Samuele Frassoni
3   Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy
,
Vincenzo Bagnardi
3   Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy
,
1   Department of Thoracic Surgery, European Institute of Oncology, Milan, Italy
,
Daniela Brambilla
4   Department of Data Management, European Institute of Oncology, Milan, Italy
,
Cristina Diotti
1   Department of Thoracic Surgery, European Institute of Oncology, Milan, Italy
,
Lorenzo Spaggiari
1   Department of Thoracic Surgery, European Institute of Oncology, Milan, Italy
2   Department of Oncology and Emato-oncology Università degli Studi di Milano, Milan, Italy
› Author Affiliations

Abstract

Background Bilateral lung neoplasms are becoming more common, but distinguishing two primary lung cancers from metastatic disease can be difficult and only long-term follow-up after treatment can disclose the real behavior of the disease.

The present study aimed to identify the appropriate candidates for bilateral surgical resections from the perspective of short-term postoperative complications and long-term outcomes.

Methods Two hundred and fifteen consecutive patients undergoing bilateral pulmonary resection for lung cancers over a 20-year period were analyzed. Preoperative patient characteristics were noted, including demographic information, operative details, pathologic information including histology and tumor stage according to the eighth edition of the tumor nodes metastases staging system, and the use of neoadjuvant or adjuvant treatments.

Results Patients receiving the second pulmonary resection more than 24 months from the first procedure as well as patients receiving bilateral lobectomies had higher overall 3-, 5-, and 10-year survival rates compared with the others.

Conclusion Patients receiving the second resection more than 24 months from the first procedure have the best long-term results irrespective of the type of resection.



Publication History

Received: 24 August 2018

Accepted: 05 March 2019

Article published online:
16 April 2019

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Stuttgart · New York

 
  • References

  • 1 De Leyn P, Moons J, Vansteenkiste J. et al. Survival after resection of synchronous bilateral lung cancer. Eur J Cardiothorac Surg 2008; 34 (06) 1215-1222
  • 2 Detterbeck FC, Franklin WA, Nicholson AG. et al; IASLC Staging and Prognostic Factors Committee; Advisory Boards; Multiple Pulmonary Sites Workgroup. The IASLC Lung Cancer Staging Project: background data and proposed criteria to distinguish separate primary lung cancers from metastatic foci in patients with two lung tumors in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol 2016; 11 (05) 651-665
  • 3 Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg 1975; 70 (04) 606-612
  • 4 Arai J, Tsuchiya T, Oikawa M. et al. Clinical and molecular analysis of synchronous double lung cancers. Lung Cancer 2012; 77 (02) 281-287
  • 5 Loukeri AA, Kampolis CF, Ntokou A, Tsoukalas G, Syrigos K. Metachronous and synchronous primary lung cancers: diagnostic aspects, surgical treatment, and prognosis. Clin Lung Cancer 2015; 16 (01) 15-23
  • 6 Shah AA, Barfield ME, Kelsey CR. et al. Outcomes after surgical management of synchronous bilateral primary lung cancers. Ann Thorac Surg 2012; 93 (04) 1055-1060 , discussion 1060
  • 7 Ivanovic J, Al-Hussaini A, Al-Shehab D. et al. Evaluating the reliability and reproducibility of the Ottawa Thoracic Morbidity and Mortality classification system. Ann Thorac Surg 2011; 91 (02) 387-393
  • 8 Harrell Jr FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15 (04) 361-387
  • 9 Clark TG, Altman DG, De Stavola BL. Quantification of the completeness of follow-up. Lancet 2002; 359 (9314): 1309-1310
  • 10 Aberle DR, Adams AM, Berg CD. et al; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011; 365 (05) 395-409
  • 11 Tsunezuka Y, Matsumoto I, Tamura M. et al. The results of therapy for bilateral multiple primary lung cancers: 30 years experience in a single centre. Eur J Surg Oncol 2004; 30 (07) 781-785
  • 12 Adebonojo SA, Moritz DM, Danby CA. The results of modern surgical therapy for multiple primary lung cancers. Chest 1997; 112 (03) 693-701
  • 13 Deschamps C, Pairolero PC, Trastek VF, Payne WS. Multiple primary lung cancers. Results of surgical treatment. J Thorac Cardiovasc Surg 1990; 99 (05) 769-777 , discussion 777–778
  • 14 Linden PA, Yeap BY, Chang MY, Henderson WG, Jaklitsch MT, Khuri S. et al. Morbidity of lung resection after prior lobectomy: results from the Veterans Affairs National Surgical Quality Improvement Program. Ann Thorac Surg 2007; 83 (02) 425-431
  • 15 Hattori A, Suzuki K, Matsunaga T. et al. Is limited resection appropriate for radiologically “solid” tumors in small lung cancers?. Ann Thorac Surg 2012; 94 (01) 212-215
  • 16 Cheng AM, Wood DE. VATS versus open surgery for lung cancer resection: moving beyond the incision. J Natl Compr Canc Netw 2015; 13 (02) 166-170
  • 17 Kaur MN, Xie F, Shiwcharan A. et al. Robotic versus video-assisted thoracoscopic lung resection during early program development. Ann Thorac Surg 2018; 105 (04) 1050-1057